TY - JOUR
T1 - OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group
AU - Gossec, Laure
AU - Paternotte, Simon
AU - Bingham, Clifton O., III
AU - Clegg, Daniel O.
AU - Coste, Philippe
AU - Conaghan, Philip G.
AU - Davis, Aileen M.
AU - Giacovelli, Giampaolo
AU - Gunther, Klaus-Peter
AU - Hawker, Gillian
AU - Hochberg, Marc C.
AU - Jordan, Joanne M.
AU - Katz, Jeffrey N.
AU - Kloppenburg, Margreet
AU - Lanzarotti, Arturo
AU - Lim, Keith
AU - Lohmander, Stefan
AU - Mahomed, Nizar N.
AU - Maillefert, Jean Francis
AU - Manno, Rebecca L.
AU - March, Lyn M.
AU - Mazzuca, Steven A.
AU - Pavelka, Karel
AU - Punzi, Leonardo
AU - Roos, Ewa M.
AU - Rovati, Lucio C.
AU - Shi, Helen
AU - Singh, Jasvinder A.
AU - Suarez-Almazor, Maria E.
AU - Tajana-Messi, Eleonora
AU - Dougados, Maxime
PY - 2011
Y1 - 2011
N2 - Objective. To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of "need for joint replacement surgery," for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA). Methods. New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons' indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA. Results. In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%-12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0-100) + physical function (0-100) > 80]. Conclusion. These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define "nonresponders" to disease-modifying drugs in OA clinical trials. (J Rheumatol 2011;38:1765-9; doi:10.3899/jrheum.110403)
AB - Objective. To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of "need for joint replacement surgery," for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA). Methods. New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons' indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA. Results. In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%-12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0-100) + physical function (0-100) > 80]. Conclusion. These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define "nonresponders" to disease-modifying drugs in OA clinical trials. (J Rheumatol 2011;38:1765-9; doi:10.3899/jrheum.110403)
KW - OSTEOARTHRITIS
KW - SEVERITY
KW - PAIN
KW - FUNCTION
KW - STRUCTURE OUTCOME MEASURE
U2 - 10.3899/jrheum.110403
DO - 10.3899/jrheum.110403
M3 - Article
C2 - 21807799
SN - 0315-162X
VL - 38
SP - 1765
EP - 1769
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 8
ER -